Looking back on testing & diagnostics services stocks’ Q2 earnings, we examine this quarter’s best and worst performers, ...

LabCorp (LH) surged 27% on optimism, but moderate growth and rising capital needs temper the outlook. Read here for an ...

Access to rapidly developing diagnostic technology such as blood-based biomarkers for early detection and subsequent ...

Dr. Brian Caveney discusses how Test Finder, a novel generative AI tool, can ease clinicians’ EHR burdens through enhanced ...

Labcorp Holdings Inc. ( NYSE: LH) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 7:45 AM EDT ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Novartis will conduct a study of of anti-malaria drug hydroxychloroquine as a treatment for the coronavirus. Abbott Labs received emergency FDA clearance to market a coronavirus test kit. Here's where ...

Global medical device CRO market size was worth around USD 8.24 billion in 2024 and is predicted to grow to around USD 19.69 billion by 2034, (CAGR) of 9.10%. The global medical device CRO market size ...

A group of tenants living in properties managed by ARHA recounted their abysmal living conditions and distrust of the organization to City Council.

The multimillion-dollar acquisition involves cancer diagnostics and related lab testing services from a subsidiary of Miami ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today ...

Labcorp's $225M acquisition of BioReference Health select assets boosts its oncology diagnostics portfolio and expands patient access nationwide.